Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Chemmedchem|July 26, 2017
Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in vitro and ex vivo StudyNatalia Estrada-Ortiz, Federica Guarra, Inge A M de Graaf, et al.
Bioorganic & Medicinal Chemistry|November 26, 2010
Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthronesFrancesca Sorrentino, Anastasia Karioti, Paola Gratteri, et al.
Angewandte Chemie (International Ed. in English)|July 8, 2020
124 I Radiolabeling of a AuIII -NHC Complex for In Vivo Biodistribution StudiesFederica Guarra, Alessio Terenzi, Christine Pirker, et al.
Metallomics : Integrated Biometal Science|February 11, 2012
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compoundsFrancesca Guidi, Ida Landini, Michele Puglia, et al.
Chemmedchem|January 3, 2013
Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteinsKely Navakoski de Oliveira, Vincent Andermark, Susanne von Grafenstein, et al.
Journal of Medicinal Chemistry|October 7, 2008
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compoundsAngela Casini, Chiara Gabbiani, Francesca Sorrentino, et al.
Dalton Transactions (Cambridge, England : 2003)|July 31, 2015
cis-Pt I2(NH3)2: a reappraisalTiziano Marzo, Serena Pillozzi, Ondrej Hrabina, et al.
Molecular Biosystems|December 3, 2011
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compoundsFrancesca Guidi, Michele Puglia, Chiara Gabbiani, et al.
Journal of Proteomics|April 8, 2014
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c)Tania Gamberi, Lara Massai, Francesca Magherini, et al.
Pageof 11